Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis c virus related cirrhosis

Table 1 Characteristics of liver recipients with HCV-infection receiving initial steroid-free immunosuppression

#	Gender (M/F)	Rge (yr)	Child Class	HCC	HCV genotype	HCV viral load				Liver histology	Outcome (pod)
						prior	≤ 1 mo	≤ 4 mo	1 yr
5	f	60	C	no	II (1b)	104	105	104	105		died (950), ovarial-ca
9	f	62	B	no	II (1b)	105	105	106	105	AR, hepatitis (+/-)	alive (1817), reLTx (5)
12	m	57	A	yes	II (1b)	105	105	104			died (774), heart failure
13	f	59	C	yes	II (1b)	105	105	105		hepatitis (+/-), fibrosis (+)	alive (1456)
19	m	58	B	yes	II (1b)	104	103		104	hepatitis (+)	alive (1402)
20	m	46	A	yes	II (1b)	103		104	104		alive (1389)
25	f	43	C	no	II (1b)	104	104	105			died, CDF (164)

Abbreviations: # (patient number), HCC (hepatocellular carcinoma), HCV (hepatitic C virus), pod (postoperative day), yr (year), mo (mo), prior (prior to LTx), AR (acute rejection), +/++/+++/- (minimal/moderate/severe/reversed), reLTx (liver retransplantation), CDF (chronic graft dysfunction).